The Evolving Design of NIH-Funded Cardio-Oncology Studies to Address Cancer Treatment-Related Cardiovascular Toxicity

Cardiovascular (CV) toxicity from cancer therapy is a significant and growing concern. Conventional oncology clinical trial designs focused solely on cancer treatment efficacy have not provided sufficient information on both CV risk factors and outcomes. Similarly, traditional CV trials evaluating s...

Descripción completa

Detalles Bibliográficos
Autores principales: Minasian, Lori M., Dimond, Eileen, Davis, Myrtle, Adhikari, Bishow, Fagerstrom, Richard, Fabian, Carol, Floyd, Justin, Unger, Joseph M., Douglas, Pamela S., Mustian, Karen M., Chow, Eric J., Lipshultz, Steven, Hundley, W. Gregory, Armenian, Saro H., Ky, Bonnie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
State-of-the-Art Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288847/
https://www.ncbi.nlm.nih.gov/pubmed/32529192
http://dx.doi.org/10.1016/j.jaccao.2019.08.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288847/
https://www.ncbi.nlm.nih.gov/pubmed/32529192
http://dx.doi.org/10.1016/j.jaccao.2019.08.007

Ejemplares similares